Investigating a new drug for people who have multi-drug resistant HIV

Investigating a new drug for people who have multi-drug resistant HIV

HELLO – Here at the UW ACTU we are conducting a new study to evaluatean investigational drug for heavily treatment-experienced people who have multi-drug resistant HIV infection. The study drug is BMS-663068 (or fostemsavir), an attachment inhibitor that appears from early studies to be more effective than previous attachment inhibitors. As you know, combination antiretroviral […]

NEXT-PrEP NEWS from CROI 2016

NEXT-PrEP NEWS from CROI 2016

Looks like tomorrow CROI will have more NEXT-PrEP related news to catch. From: Michael Louella [mailto:mlouella@uw.edu] Sent: Tuesday, February 23, 2016 10:29 AM To: Louella, Michael W (mlouella@fhcrc.org) Subject: NEXT-PrEP NEWS from CROI 2016 Researchers Find an Alternative to Truvada as PrEP BY: DAVID HEITZ FEBRUARY 22ND, 2016